Literature DB >> 1601052

Cloricromene, a coumarine derivative, protects against lethal endotoxin shock in rats.

F Squadrito1, D Altavilla, G M Campo, G Calapai, M Ioculano, B Zingarelli, A Saitta, M Prosdocimi, A P Caputi.   

Abstract

Endotoxin shock was induced in male rats by an intravenous (i.v.) injection of Salmonella enteriditis lipopolysaccharide (LPS; 20 mg/kg i.v.). Survival rate, macrophage and serum tumor necrosis factor (TNF-alpha), mean arterial blood pressure (MAP) and white blood cell count were then evaluated. Furthermore the in vitro effect of cloricromene on peritoneal macrophage phagocytosis and TNF-alpha release by primed peritoneal macrophages was investigated. LPS administration caused animal death (0% survival 24 h after endotoxin challenge), hypotension, marked leukopenia and increased the levels of TNF-alpha in both serum and macrophage supernatants. Cloricromene administration (0.5, 1 and 2 mg/kg i.v. 15 min after endotoxin) protected against LPS-induced lethality (100% survival rate 24 h after endotoxin challenge), reverted LPS-induced hypotension and leukopenia, and decreased TNF-alpha in both serum and macrophage supernatants. Finally, cloricromene, added in vitro to peritoneal macrophages collected from endotoxin-treated rats increased macrophage phagocytosis and reduced TNF-alpha formation by activated mononuclear phagocytes. Our data suggest that cloricromene increases survival rate in endotoxin shock through an inhibition of TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601052     DOI: 10.1016/0014-2999(92)90660-v

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Authors:  D Altavilla; F Squadrito; L Ammendolia; G Squadrito; G M Campo; P Canale; M Ioculano; C Musolino; A Alonci; A Sardella; G Urna; A Saitta; A P Caputi
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

3.  Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats.

Authors:  Carmelo Muià; Emanuela Mazzon; Daniele Zito; Daniele Maiere; Domenico Britti; Concetta Crisafulli; Giacomo Oteri; Giancarlo Cordasco; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-28       Impact factor: 3.000

4.  Cloricromene in endotoxemia: role of NF-kappaB.

Authors:  A Ianaro; P Maffia; G Grassia; P Di Meglio; R Sorrentino; R d'Emmanuele di Villa Bianca; M Di Rosa; A Ialenti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-30       Impact factor: 3.000

5.  Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.

Authors:  P S Lidbury; R Cirillo; J R Vane
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; P Canale; M Ioculano; G M Campo; L Ammendolia; M Ferlito; B Zingarelli; G Squadrito; A Saitta
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury.

Authors:  G Calapai; F Squadrito; A Rizzo; M C Marciano; G M Campo; A P Caputi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

8.  Inhibition of human monocyte adhesion to endothelial cells by the coumarin derivative, cloricromene.

Authors:  S Tranchina; S Bernasconi; E Dejana; A Del Maschio
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.